Abstract
The Anamnestic Comparative Self-Assessment is a method by which cancer patients numerically express their overall subjective level of the quality of life. A personal scale of well-being is constructed around the patient's memory of the best and worst periods in his or her life expericnce. The method was validated in a pilot study of 65 patients with various malignancies. It is proposed for application as one of the end points of cancer clinical trials.